Concepts (201)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Echocardiography | 19 | 2022 | 515 | 4.920 |
Why?
|
| Heart Ventricles | 14 | 2022 | 738 | 4.070 |
Why?
|
| Heart Defects, Congenital | 14 | 2021 | 596 | 3.040 |
Why?
|
| Ventricular Function, Left | 9 | 2022 | 481 | 2.870 |
Why?
|
| Cardiac Catheterization | 13 | 2020 | 419 | 2.270 |
Why?
|
| Myocardial Contraction | 6 | 2018 | 383 | 1.830 |
Why?
|
| Heart Transplantation | 5 | 2021 | 328 | 1.780 |
Why?
|
| Stroke Volume | 8 | 2022 | 586 | 1.700 |
Why?
|
| Pulmonary Valve Insufficiency | 3 | 2015 | 24 | 1.420 |
Why?
|
| Ventricular Pressure | 4 | 2017 | 82 | 1.190 |
Why?
|
| Child, Preschool | 19 | 2021 | 3187 | 1.100 |
Why?
|
| Child | 26 | 2022 | 6401 | 1.080 |
Why?
|
| Graft Rejection | 2 | 2021 | 458 | 1.040 |
Why?
|
| Fontan Procedure | 3 | 2022 | 129 | 1.030 |
Why?
|
| Obesity | 3 | 2020 | 1074 | 1.010 |
Why?
|
| Thinness | 2 | 2015 | 14 | 0.980 |
Why?
|
| Infant | 15 | 2021 | 2891 | 0.940 |
Why?
|
| Pulmonary Valve | 2 | 2015 | 40 | 0.940 |
Why?
|
| Hypoplastic Left Heart Syndrome | 4 | 2021 | 138 | 0.920 |
Why?
|
| Body Mass Index | 2 | 2020 | 866 | 0.910 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2017 | 277 | 0.910 |
Why?
|
| Coronary Vessel Anomalies | 2 | 2020 | 45 | 0.880 |
Why?
|
| Reproducibility of Results | 11 | 2020 | 2077 | 0.870 |
Why?
|
| Barth Syndrome | 1 | 2022 | 5 | 0.830 |
Why?
|
| Transposition of Great Vessels | 2 | 2021 | 51 | 0.820 |
Why?
|
| Norwood Procedures | 3 | 2017 | 61 | 0.790 |
Why?
|
| Adolescent | 20 | 2022 | 8904 | 0.760 |
Why?
|
| Echocardiography, Three-Dimensional | 2 | 2018 | 38 | 0.760 |
Why?
|
| Ductus Arteriosus, Patent | 2 | 2019 | 38 | 0.760 |
Why?
|
| Ventricular Function, Right | 3 | 2016 | 103 | 0.730 |
Why?
|
| Female | 34 | 2022 | 38021 | 0.700 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2020 | 106 | 0.700 |
Why?
|
| Male | 35 | 2022 | 37283 | 0.700 |
Why?
|
| Heart Valve Prosthesis Implantation | 4 | 2020 | 164 | 0.700 |
Why?
|
| Preoperative Care | 3 | 2019 | 275 | 0.680 |
Why?
|
| Vascular Surgical Procedures | 2 | 2017 | 168 | 0.680 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2020 | 140 | 0.660 |
Why?
|
| Humans | 46 | 2022 | 68549 | 0.660 |
Why?
|
| Arterial Switch Operation | 1 | 2018 | 10 | 0.650 |
Why?
|
| Cardiac Surgical Procedures | 4 | 2021 | 450 | 0.630 |
Why?
|
| Waist-Height Ratio | 1 | 2017 | 1 | 0.620 |
Why?
|
| Coronary Stenosis | 1 | 2020 | 246 | 0.620 |
Why?
|
| Waist-Hip Ratio | 1 | 2017 | 14 | 0.620 |
Why?
|
| Anthropometry | 1 | 2017 | 64 | 0.610 |
Why?
|
| Sinus of Valsalva | 1 | 2017 | 9 | 0.610 |
Why?
|
| Absorptiometry, Photon | 1 | 2017 | 83 | 0.610 |
Why?
|
| Risk Assessment | 4 | 2017 | 2004 | 0.600 |
Why?
|
| Aortic Rupture | 1 | 2017 | 32 | 0.600 |
Why?
|
| Length of Stay | 4 | 2019 | 780 | 0.600 |
Why?
|
| Infant, Newborn | 12 | 2021 | 2455 | 0.600 |
Why?
|
| Retrospective Studies | 15 | 2022 | 7268 | 0.590 |
Why?
|
| Hospital Mortality | 4 | 2021 | 384 | 0.590 |
Why?
|
| Echocardiography, Doppler | 2 | 2014 | 87 | 0.590 |
Why?
|
| Aortic Aneurysm | 1 | 2017 | 77 | 0.580 |
Why?
|
| Prospective Studies | 9 | 2020 | 3703 | 0.580 |
Why?
|
| Vasoconstrictor Agents | 1 | 2017 | 107 | 0.570 |
Why?
|
| Transplant Recipients | 1 | 2017 | 109 | 0.560 |
Why?
|
| Pediatric Obesity | 1 | 2017 | 92 | 0.550 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2018 | 237 | 0.540 |
Why?
|
| Heart Valve Prosthesis | 2 | 2014 | 222 | 0.530 |
Why?
|
| Blood Pressure Determination | 1 | 2016 | 151 | 0.510 |
Why?
|
| Infant, Premature | 1 | 2017 | 284 | 0.510 |
Why?
|
| Body Weight | 2 | 2019 | 554 | 0.480 |
Why?
|
| Decision Support Techniques | 1 | 2016 | 191 | 0.480 |
Why?
|
| Carotid Intima-Media Thickness | 1 | 2014 | 54 | 0.460 |
Why?
|
| Sex Characteristics | 1 | 2015 | 295 | 0.440 |
Why?
|
| Cross-Sectional Studies | 5 | 2022 | 2265 | 0.440 |
Why?
|
| Heart Failure | 1 | 2022 | 1179 | 0.430 |
Why?
|
| Models, Theoretical | 1 | 2015 | 384 | 0.420 |
Why?
|
| Young Adult | 10 | 2020 | 5710 | 0.420 |
Why?
|
| Diastole | 4 | 2022 | 161 | 0.410 |
Why?
|
| Sensitivity and Specificity | 5 | 2019 | 1753 | 0.410 |
Why?
|
| Risk Factors | 7 | 2022 | 5720 | 0.350 |
Why?
|
| Predictive Value of Tests | 6 | 2021 | 1465 | 0.340 |
Why?
|
| Exercise | 1 | 2015 | 658 | 0.340 |
Why?
|
| Myocardium | 1 | 2015 | 1204 | 0.340 |
Why?
|
| Postoperative Period | 3 | 2021 | 238 | 0.330 |
Why?
|
| Blood Pressure | 2 | 2015 | 1449 | 0.330 |
Why?
|
| Ventricular Function | 3 | 2017 | 93 | 0.300 |
Why?
|
| Treatment Outcome | 6 | 2017 | 7028 | 0.300 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2019 | 181 | 0.290 |
Why?
|
| Follow-Up Studies | 4 | 2017 | 3256 | 0.280 |
Why?
|
| Aneurysm, False | 2 | 2017 | 60 | 0.280 |
Why?
|
| South Carolina | 3 | 2020 | 2752 | 0.270 |
Why?
|
| Elasticity Imaging Techniques | 2 | 2017 | 14 | 0.270 |
Why?
|
| Computed Tomography Angiography | 3 | 2019 | 424 | 0.260 |
Why?
|
| Cohort Studies | 3 | 2021 | 2356 | 0.240 |
Why?
|
| Pulmonary Artery | 2 | 2017 | 323 | 0.230 |
Why?
|
| Equipment Failure Analysis | 2 | 2014 | 121 | 0.220 |
Why?
|
| Heart Diseases | 2 | 2016 | 276 | 0.220 |
Why?
|
| Age Factors | 2 | 2018 | 1860 | 0.220 |
Why?
|
| Prevalence | 2 | 2020 | 1609 | 0.210 |
Why?
|
| Feasibility Studies | 2 | 2016 | 652 | 0.210 |
Why?
|
| Cardiolipins | 1 | 2022 | 12 | 0.210 |
Why?
|
| Incidence | 2 | 2017 | 1582 | 0.200 |
Why?
|
| Prognosis | 2 | 2018 | 2093 | 0.200 |
Why?
|
| Hospital Rapid Response Team | 1 | 2021 | 9 | 0.190 |
Why?
|
| Lost to Follow-Up | 1 | 2020 | 7 | 0.180 |
Why?
|
| Heart Arrest | 1 | 2021 | 113 | 0.180 |
Why?
|
| Transition to Adult Care | 1 | 2020 | 18 | 0.180 |
Why?
|
| Constriction, Pathologic | 1 | 2020 | 236 | 0.180 |
Why?
|
| Magnetic Resonance Imaging, Cine | 2 | 2017 | 83 | 0.180 |
Why?
|
| Gestational Age | 2 | 2019 | 389 | 0.180 |
Why?
|
| Accidents, Traffic | 2 | 2017 | 109 | 0.170 |
Why?
|
| Radiation Exposure | 1 | 2020 | 84 | 0.170 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2019 | 36 | 0.170 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2017 | 333 | 0.160 |
Why?
|
| Coronary Angiography | 2 | 2021 | 866 | 0.160 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 1140 | 0.160 |
Why?
|
| Aortic Valve Stenosis | 1 | 2020 | 177 | 0.160 |
Why?
|
| Ventricular Dysfunction | 1 | 2017 | 15 | 0.150 |
Why?
|
| Hospitals, University | 1 | 2018 | 169 | 0.150 |
Why?
|
| United States | 3 | 2015 | 7338 | 0.150 |
Why?
|
| Enteral Nutrition | 1 | 2019 | 157 | 0.150 |
Why?
|
| Ligation | 1 | 2017 | 83 | 0.150 |
Why?
|
| Vascular System Injuries | 1 | 2017 | 20 | 0.150 |
Why?
|
| Multivariate Analysis | 2 | 2020 | 1046 | 0.150 |
Why?
|
| Heart Bypass, Right | 1 | 2017 | 30 | 0.150 |
Why?
|
| Odds Ratio | 2 | 2016 | 880 | 0.140 |
Why?
|
| Monitoring, Physiologic | 1 | 2018 | 219 | 0.140 |
Why?
|
| Dyslipidemias | 1 | 2017 | 98 | 0.140 |
Why?
|
| Angioplasty, Balloon | 1 | 2017 | 110 | 0.140 |
Why?
|
| Acute Kidney Injury | 1 | 2019 | 232 | 0.140 |
Why?
|
| Cardiac Catheters | 2 | 2014 | 12 | 0.140 |
Why?
|
| Self Expandable Metallic Stents | 1 | 2016 | 14 | 0.140 |
Why?
|
| Time Factors | 4 | 2019 | 4655 | 0.140 |
Why?
|
| Myocardial Ischemia | 1 | 2017 | 172 | 0.140 |
Why?
|
| Clinical Decision-Making | 1 | 2017 | 109 | 0.140 |
Why?
|
| Logistic Models | 2 | 2019 | 1419 | 0.140 |
Why?
|
| Anesthesia, General | 1 | 2016 | 86 | 0.140 |
Why?
|
| Equipment Design | 2 | 2014 | 500 | 0.130 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2017 | 134 | 0.130 |
Why?
|
| Insulin Resistance | 1 | 2017 | 241 | 0.130 |
Why?
|
| Prosthesis Design | 2 | 2017 | 301 | 0.130 |
Why?
|
| Adult | 6 | 2019 | 21379 | 0.130 |
Why?
|
| Sildenafil Citrate | 1 | 2015 | 23 | 0.130 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2015 | 25 | 0.130 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2016 | 131 | 0.130 |
Why?
|
| Perioperative Care | 1 | 2016 | 100 | 0.130 |
Why?
|
| Coronary Vessels | 1 | 2017 | 313 | 0.120 |
Why?
|
| Multidetector Computed Tomography | 1 | 2015 | 60 | 0.120 |
Why?
|
| Microarray Analysis | 1 | 2014 | 63 | 0.120 |
Why?
|
| Demography | 1 | 2015 | 279 | 0.120 |
Why?
|
| Chromosome Aberrations | 1 | 2014 | 86 | 0.120 |
Why?
|
| Aorta, Thoracic | 1 | 2016 | 211 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2021 | 2324 | 0.120 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2016 | 186 | 0.120 |
Why?
|
| Exercise Test | 1 | 2015 | 242 | 0.120 |
Why?
|
| Internationality | 1 | 2014 | 74 | 0.120 |
Why?
|
| Survival Rate | 1 | 2017 | 1055 | 0.120 |
Why?
|
| Comparative Effectiveness Research | 1 | 2014 | 36 | 0.120 |
Why?
|
| United Kingdom | 1 | 2014 | 152 | 0.110 |
Why?
|
| Pilot Projects | 1 | 2017 | 1341 | 0.110 |
Why?
|
| Biopsy | 1 | 2015 | 539 | 0.110 |
Why?
|
| Models, Cardiovascular | 1 | 2014 | 133 | 0.110 |
Why?
|
| Stents | 1 | 2017 | 657 | 0.110 |
Why?
|
| Pulmonary Embolism | 1 | 2015 | 253 | 0.110 |
Why?
|
| Patient Selection | 1 | 2016 | 592 | 0.100 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 848 | 0.100 |
Why?
|
| Recovery of Function | 1 | 2015 | 506 | 0.100 |
Why?
|
| Inflammation | 1 | 2017 | 1030 | 0.100 |
Why?
|
| Postoperative Complications | 1 | 2017 | 1615 | 0.090 |
Why?
|
| Comorbidity | 1 | 2014 | 1425 | 0.090 |
Why?
|
| Respiration | 2 | 2019 | 91 | 0.080 |
Why?
|
| Cardiopulmonary Bypass | 2 | 2021 | 250 | 0.070 |
Why?
|
| Calcium Chloride | 1 | 2021 | 38 | 0.050 |
Why?
|
| Exercise Tolerance | 1 | 2022 | 75 | 0.050 |
Why?
|
| Infant, Low Birth Weight | 1 | 2021 | 84 | 0.050 |
Why?
|
| Electrocardiography | 1 | 2022 | 601 | 0.040 |
Why?
|
| Inpatients | 1 | 2021 | 208 | 0.040 |
Why?
|
| Birth Weight | 1 | 2019 | 186 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2021 | 344 | 0.040 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2019 | 101 | 0.040 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 167 | 0.040 |
Why?
|
| Cardiovascular Agents | 1 | 2019 | 82 | 0.040 |
Why?
|
| Aortic Valve | 1 | 2020 | 249 | 0.040 |
Why?
|
| Disease Management | 1 | 2020 | 248 | 0.040 |
Why?
|
| Radiation Dosage | 1 | 2021 | 419 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2020 | 737 | 0.040 |
Why?
|
| Primary Graft Dysfunction | 1 | 2017 | 12 | 0.040 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2017 | 101 | 0.040 |
Why?
|
| Oxygen | 1 | 2019 | 386 | 0.040 |
Why?
|
| Anesthetics | 1 | 2016 | 30 | 0.040 |
Why?
|
| Blood Volume | 1 | 2016 | 47 | 0.040 |
Why?
|
| Reference Standards | 1 | 2016 | 115 | 0.030 |
Why?
|
| Systole | 1 | 2016 | 149 | 0.030 |
Why?
|
| Sodium Chloride | 1 | 2016 | 136 | 0.030 |
Why?
|
| Adrenergic beta-1 Receptor Agonists | 1 | 2015 | 4 | 0.030 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2016 | 102 | 0.030 |
Why?
|
| Dobutamine | 1 | 2015 | 25 | 0.030 |
Why?
|
| Manometry | 1 | 2016 | 276 | 0.030 |
Why?
|
| Heart | 1 | 2019 | 850 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 1851 | 0.030 |
Why?
|
| Miniaturization | 1 | 2014 | 21 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2014 | 159 | 0.030 |
Why?
|
| Biomarkers | 1 | 2017 | 1593 | 0.030 |
Why?
|
| Palliative Care | 1 | 2014 | 271 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 2798 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2015 | 1738 | 0.020 |
Why?
|
| Aged | 1 | 2020 | 14842 | 0.010 |
Why?
|
| Middle Aged | 1 | 2017 | 21119 | 0.010 |
Why?
|